Outcomes in randomized trials of tracheal intubation in the critically ill: A systematic review.

Am J Emerg MedJul 23, 2026 (epub)

Takatoshi Koroki, Yuki Kotani, Tomohisa Nagayama et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review analyzed 43 randomized controlled trials on tracheal intubation in critically ill adults. The study identified 15 primary and 46 secondary outcomes, with hypoxemia being the most reported primary outcome in 28% of studies. The findings highlight a focus on short-term physiological and procedural outcomes rather than patient-centered recovery metrics.

Key findings

  • Hypoxemia was the most frequently reported primary outcome in 12 studies (28%).
  • First-pass success was reported as a primary outcome in 11 studies (26%).
  • Common secondary outcomes included hypoxemia in 26 studies (60%) and mortality in 21 studies (49%).
  • Only minimal attention was given to patient-centered recovery outcomes.

Why it matters

Understanding the outcomes prioritized in tracheal intubation trials can inform clinicians about the focus of current research and highlight the need for more comprehensive outcome measures that include patient-centered recovery metrics.

Source

Published in Am J Emerg Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Emergency Medicine

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.